Brief: Astellas And Sutro Biopharma Announce Worldwide Strategic Collaboration To Advance Novel Immunostimulatory Antibody-Drug Conjugates

Sutro Biopharma

28/06/2022 24:32

June 27 (Reuters) - Astellas Pharma Inc  4503.T :
    * ASTELLAS AND SUTRO BIOPHARMA ANNOUNCE WORLDWIDE STRATEGIC
COLLABORATION TO ADVANCE NOVEL IMMUNOSTIMULATORY ANTIBODY-DRUG
CONJUGATES (IADCS)
    * SUTRO BIOPHARMA INC - WILL RECEIVE AN UPFRONT PAYMENT OF
US$90
MILLION TO DEVELOP IADCS FOR THREE BIOLOGICAL TARGETS
    * SUTRO -  MAY BE ELIGIBLE TO RECEIVE UP TO ADDITIONAL
$422.5
MILLION IN MILESTONES FOR EACH PRODUCT CANDIDATE PLUS ROYALTIES

Source text for Eikon:  ID:nPnp97vJa 
Further company coverage:  4503.T 

 ((Reuters.Brief@thomsonreuters.com;))